2025-06-09-Jefferies-阿杜斯家庭护理公司（ADUS）_伊利诺伊州和德克萨斯州的费率上调支持健康的费率环境；建议买入_7页_101kb

报告摘要

USA Healthcare Services Equity Research Summary: Addus HomeCare (ADUS)

FLASH NOTE

Rating: BUY
Price Target: $160.00 (+37% upside from $116.56)
Key update: ADUS announced finalized budget approvals for rate increases in two key states, Illinois (IL) and Texas (TX), supporting additional revenue.

State Rate Increases

IL: Approved +3.9% rate increase for FY26, raising base hourly reimbursement to $30.80 (supports minimum wage of $18.75). Effective Jan 1, 2026, expected to add ~$17.5M annualized revenue with margins in low-20%.
TX: Approved +9.9% rate increase for FY26, raising base hourly reimbursement to $17.13. Effective Sept 1, 2025, expected to add ~$17.7M annualized revenue with margins slightly above 20% after wage adjustments.

Analyst Outlook

The favorable rate environment supports revenue growth above ADUS's 3–5% target through FY26, likely driving upside versus current Street expectations. Analysts remain optimistic about additional state rate increase opportunities (e.g., NM, PA), reinforcing the company's growth trajectory and stock potential. Risk factors include wage inflation, hiring difficulties, and merger integration.

Valuation & Risks

Rating: BUY (seeks 15-20%+ total return over 12M).
Key Metrics: Price Target $160.00, Current Price $116.56, Market Cap $2.1B.
Risks: Wage inflation, staffing challenges, acquisition integration.

Summary Key Points

Revenue Impact: Immediate +$35.2M from IL and TX rate increases.
Growth Driver: Positive state Medicaid rate developments sustain healthy growth and stock upside.
Recommendation: Reit "Buy" driven by stronger-than-expected revenue growth and future rate opportunities.

展开完整摘要